IMA vs REGN: Which Stock is Better?
Side-by-side comparison of Imagenebio Inc and Regeneron Pharmaceuticals Inc in 2026
IMA
Imagenebio Inc
$4.90
REGN
Regeneron Pharmaceuticals Inc
$755.51
Key Metrics Comparison
| Metric | IMA | REGN | Winner |
|---|---|---|---|
| Market Cap | $54.83M | $78.92B | REGN |
| P/E Ratio | N/A | 17.99 | REGN |
| EPS (TTM) | $N/A | $41.50 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 100.0% | 44.6% | IMA |
Analyze IMA
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMA or REGN a better investment?
Comparing IMA and REGN: Imagenebio Inc has a market cap of $54.83M while Regeneron Pharmaceuticals Inc has $78.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMA and REGN?
IMA (Imagenebio Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMA or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMA or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for IMA.
Which company is more profitable: IMA or REGN?
Imagenebio Inc (IMA) has higher gross margins at 100.0% compared to 44.6% for REGN.
Which is the larger company: IMA or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.92B compared to $54.83M for IMA.
Should I buy IMA or REGN in 2026?
Both IMA and REGN have investment merit. IMA trades at $4.90 while REGN trades at $755.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMA and REGN stock?
Key differences: Market Cap ($54.83M vs $78.92B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.0% vs 0.0%), Gross Margin (100.0% vs 44.6%).